Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The effects of lymph node status on predicting outcome in ER+ /HER2- tamoxifen treated breast cancer patients using gene signatures.

Autor: Cockburn JG; Department of Oncology, Juravinski Hospital and Cancer Centre, Hamilton, Canada., Hallett RM; Department of Biochemistry and Biomedical Sciences, Centre for Functional Genomics, McMaster University, Hamilton, Canada., Gillgrass AE; Department of Oncology, Juravinski Hospital and Cancer Centre, Hamilton, Canada., Dias KN; Department of Oncology, Juravinski Hospital and Cancer Centre, Hamilton, Canada., Whelan T; Department of Oncology, Juravinski Hospital and Cancer Centre, Hamilton, Canada., Levine MN; Department of Oncology, Juravinski Hospital and Cancer Centre, Hamilton, Canada., Hassell JA; Department of Biochemistry and Biomedical Sciences, Centre for Functional Genomics, McMaster University, Hamilton, Canada., Bane A; Department of Oncology, Juravinski Hospital and Cancer Centre, Hamilton, Canada. bane@hhsc.ca.; Department of Pathology, Juravinski Hospital and Cancer Centre, Hamilton, Canada. bane@hhsc.ca.

Publikováno v: BMC cancer [BMC Cancer] 2016 Jul 28; Vol. 16, pp. 555. Date of Electronic Publication: 2016 Jul 28.

T helper cell IL-4 drives intestinal Th2 priming to oral peanut antigen, under the control of OX40L and independent of innate-like lymphocytes.

Autor: Chu DK; Departments of Pathology and Molecular Medicine, McMaster Immunology Research Centre, McMaster University, Hamilton, Ontario, Canada., Mohammed-Ali Z; Departments of Pathology and Molecular Medicine, McMaster Immunology Research Centre, McMaster University, Hamilton, Ontario, Canada., Jiménez-Saiz R; Departments of Pathology and Molecular Medicine, McMaster Immunology Research Centre, McMaster University, Hamilton, Ontario, Canada., Walker TD; Departments of Pathology and Molecular Medicine, McMaster Immunology Research Centre, McMaster University, Hamilton, Ontario, Canada., Goncharova S; Departments of Pathology and Molecular Medicine, McMaster Immunology Research Centre, McMaster University, Hamilton, Ontario, Canada., Llop-Guevara A; Departments of Pathology and Molecular Medicine, McMaster Immunology Research Centre, McMaster University, Hamilton, Ontario, Canada., Kong J; Departments of Pathology and Molecular Medicine, McMaster Immunology Research Centre, McMaster University, Hamilton, Ontario, Canada., Gordon ME; Departments of Pathology and Molecular Medicine, McMaster Immunology Research Centre, McMaster University, Hamilton, Ontario, Canada., Barra NG; Departments of Pathology and Molecular Medicine, McMaster Immunology Research Centre, McMaster University, Hamilton, Ontario, Canada., Gillgrass AE; Departments of Pathology and Molecular Medicine, McMaster Immunology Research Centre, McMaster University, Hamilton, Ontario, Canada., Van Seggelen H; Departments of Pathology and Molecular Medicine, McMaster Immunology Research Centre, McMaster University, Hamilton, Ontario, Canada., Khan WI; Departments of Pathology and Molecular Medicine, Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Ontario, Canada., Ashkar AA; Departments of Pathology and Molecular Medicine, McMaster Immunology Research Centre, McMaster University, Hamilton, Ontario, Canada., Bramson JL; Departments of Pathology and Molecular Medicine, McMaster Immunology Research Centre, McMaster University, Hamilton, Ontario, Canada., Humbles AA; Departments of Respiratory, Inflammation and Autoimmunity, MedImmune LLC, Gaithersburg, Maryland, USA., Kolbeck R; Departments of Respiratory, Inflammation and Autoimmunity, MedImmune LLC, Gaithersburg, Maryland, USA., Waserman S; Department of Medicine, McMaster University, Hamilton, Ontario, Canada., Jordana M; Departments of Pathology and Molecular Medicine, McMaster Immunology Research Centre, McMaster University, Hamilton, Ontario, Canada.

Publikováno v: Mucosal immunology [Mucosal Immunol] 2014 Nov; Vol. 7 (6), pp. 1395-404. Date of Electronic Publication: 2014 Apr 30.

FimH, a TLR4 ligand, induces innate antiviral responses in the lung leading to protection against lethal influenza infection in mice.

Autor: Abdul-Careem MF; Center for Gene Therapeutics, Department of Pathology and Molecular Medicine, McMaster University Health Sciences Center, 1200 Main Street West, Hamilton, Ontario, Canada L8N 3Z5., Firoz Mian M, Gillgrass AE, Chenoweth MJ, Barra NG, Chan T, Al-Garawi AA, Chew MV, Yue G, van Roojen N, Xing Z, Ashkar AA

Publikováno v: Antiviral research [Antiviral Res] 2011 Nov; Vol. 92 (2), pp. 346-55. Date of Electronic Publication: 2011 Sep 14.